Asia Pacific Clinical Trial Equipment & Ancillary Solutions Market Size & Outlook
Related Markets
Asia Pacific clinical trial equipment & ancillary solutions market highlights
- The Asia Pacific clinical trial equipment & ancillary solutions market generated a revenue of USD 780.8 million in 2024.
- The market is expected to grow at a CAGR of 10.2% from 2025 to 2033.
- In terms of segment, supply/logistics was the largest revenue generating type in 2024.
- Supply/Logistics is the most lucrative type segment registering the fastest growth during the forecast period.
- Country-wise, South Korea is expected to register the highest CAGR from 2025 to 2033.
Asia Pacific data book summary
| Market revenue in 2024 | USD 780.8 million |
| Market revenue in 2033 | USD 1,874.1 million |
| Growth rate | 10.2% (CAGR from 2025 to 2033) |
| Largest segment | Supply/logistics |
| Fastest growing segment | Supply/Logistics |
| Historical data covered | 2021 - 2023 |
| Base year for estimation | 2024 |
| Forecast period covered | 2025 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Sourcing, Supply/Logistics, Service |
| Key market players worldwide | Woodley Equipment Company, PAREXEL, Thermo Fisher Scientific Inc, Cadila Pharmaceuticals, United Parcel Service Inc Class B, Ancillare, Imperial CRS, Emser, Quipment, Myonex, Yourway |
Other key industry trends
- In terms of revenue, Asia Pacific region accounted for 24.4% of the global clinical trial equipment & ancillary solutions market in 2024.
- Globally, North America is projected to lead the regional market in terms of revenue in 2033.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 1,874.1 million by 2033.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Clinical Trial Equipment & Ancillary Solutions Market Scope
Clinical Trial Equipment & Ancillary Solutions Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Yourway | View profile | 51-100 | Allentown, Pennsylvania, United States, North America | http://www.yourway.com |
| Myonex | View profile | 101-250 | Horsham, Pennsylvania, United States, North America | https://www.myonex.com/ |
| Quipment | View profile | 51-100 | Nancy, Lorraine, France, Europe | https://www.quipment.fr |
| Emser | View profile | 51-100 | Leiden, Zuid-Holland, The Netherlands, Europe | https://www.emsere.com |
| Imperial CRS | View profile | 251-500 | Grand Rapids, Michigan, United States, North America | http://www.imperialcrs.com |
| Ancillare | View profile | 251-500 | Horsham, Pennsylvania, United States, North America | https://www.ancillare.com |
| Cadila Pharmaceuticals | View profile | 5001-10000 | Ahmedabad, Gujarat, India, Asia | http://cadilapharma.com |
| PAREXEL | View profile | 10001+ | Waltham, Massachusetts, United States, North America | http://www.parexel.com |
| United Parcel Service Inc Class B | View profile | 500000 | 55 Glenlake Parkway, N.E. Atlanta, Atlanta, GA, United States, 30328 | https://www.ups.com |
| Woodley Equipment Company | View profile | 101-250 | Bolton, Bolton, United Kingdom, Europe | http://www.woodleyequipment.com |
| Thermo Fisher Scientific Inc | View profile | 122000 | 168 Third Avenue, Waltham, MA, United States, 02451 | https://www.thermofisher.com |
Asia Pacific clinical trial equipment & ancillary solutions market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to clinical trial equipment & ancillary solutions market will help companies and investors design strategic landscapes.
Supply/logistics was the largest segment with a revenue share of 37.17% in 2024. Horizon Databook has segmented the Asia Pacific clinical trial equipment & ancillary solutions market based on sourcing, supply/logistics, service covering the revenue growth of each sub-segment from 2021 to 2033.
Asia Pacific accounted for 23.7% market share of global clinical trial equipment & ancillary solutions market as it is considered as the fastest growing market as many developed nations are investing in Asia-Pacific regions. Clinical trials is increasing in Asia as compared to North America, and Europe. This is due to the large patient pool & low trial cost. \
Asia pacific is recognized by the clinical phase biotechnology firms for accelerated patient enrollment especially in infectious diseases, oncology, metabolic conditions, immune-oncology, and rare diseases. The clinical research activity has increased by 10% each year over the past few years.
There are also key opinion leaders, and centers of excellence across various therapeutic areas in the region. For instance, Seoul National University Hospital, and the National Taiwan University with expertise in oncology & cardiovascular diseases.
Reasons to subscribe to Asia Pacific clinical trial equipment & ancillary solutions market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Asia Pacific clinical trial equipment & ancillary solutions market databook
-
Our clientele includes a mix of clinical trial equipment & ancillary solutions market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific clinical trial equipment & ancillary solutions market , including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific clinical trial equipment & ancillary solutions market from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Partial client list
Asia Pacific clinical trial equipment & ancillary solutions market size, by country, 2021-2033 (US$M)
Asia Pacific Clinical Trial Equipment & Ancillary Solutions Market Outlook Share, 2024 & 2033 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
